Clinical Trial

Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma

Name: Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma — clinical trial record (NCT07726329)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The prognosis of advanced hepatocellular carcinoma is poor. In this study, the eligible patients will be treated by tumor antigen-pulsed autologous dendritic cells and followed by TACE. The end points are to see tumor response and patient survival.

Trial Details

NCT Number	NCT07726329
Lead Sponsor	Chang Gung Memorial Hospital
Conditions	Liver Neoplasms
Enrollment	100 participants
Start Date	2019-07-01
Primary Completion	2028-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-07-24